RCUS

Arcus Biosciences, Inc.

RCUS·03969F109·US·Common Stock·Healthcare - Biotechnology-Activist

RCUS (Arcus Biosciences, Inc.) is held by 120 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($506.1M), STATE STREET CORP ($185.9M), WELLINGTON MANAGEMENT GROUP LLP ($181.8M). Net institutional sentiment: Mixed.

120
Holders
(8 Elite)
$2.3B
Total Value
58% (125)
Consensus
73 buying - 52 selling
13F: Insider & Congress: Updated regularly
RCUS

Smart Money Verdict

View all
Loading verdict
Held by 120 funds
8 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 24, 2026 · Activists Aug 7, 2026 · Congress none

InsiderAAAzoy AlexanderExercise 3K shAug 21, 2026
InsiderAAAzoy AlexanderSell $85KAug 21, 2026
ActivistGSGilead Sciences, Inc.24.7%Aug 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
16.4M(+7.8%)$506.1M0.0%+80.76%
34
Increased
6M(+11.4%)$185.9M0.0%+50.88%
34
Decreased
5.9M(-3.2%)$181.8M0.0%+51.84%
0
Increased
4.5M(+4.8%)$138M0.0%+34.84%
32
Increased
4M(+247.5%)$124.9M0.0%+17.70%
49
Increased
3.9M(+0.8%)$119.9M0.0%+36.72%
30
Increased
3.1M(+135.7%)$96.7M0.0%+14.04%
48
Decreased
3M(-20.4%)$92.7M0.3%+110.20%
0
Increased
2.4M(+8.7%)$75.5M0.0%+63.71%
32
Decreased
2.1M(-2.3%)$66M0.0%+56.65%
0
Decreased
1.9M(-48.3%)$60M0.0%+32.87%
0
Increased
1.4M(+0.6%)$44.2M0.0%+76.46%
29
Decreased
1.4M(-14.2%)$43.8M0.0%+53.05%
0
Increased
1.4M(+38.8%)$42.8M0.0%+63.68%
38
Increased
941,756(+4.2%)$29M0.0%+84.84%
30
Increased
932,523(+11.0%)$28.7M0.0%+67.06%
32
Increased
845,233(+3.0%)$26.1M0.0%+37.92%
30
Increased
844,816(+103.3%)$26M0.1%+14.12%
55
Increased
835,504(+29.3%)$25.8M0.0%+87.37%
36
Decreased
795,912(-28.5%)$24.5M0.0%+183.60%
0

Showing 1-20 of 132

1 / 7
RCUSRCUSArcus Biosciences, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used